What is Dermatomyositis?
Dermatomyositis is an autoimmune disease causing inflammation of the muscles together with a distinctive rash. Weakness affects the shoulders and hips first — difficulty climbing stairs, rising from a chair or lifting the arms — and develops over weeks to months. The rash often appears before the weakness and is what makes early diagnosis possible.
Also called: DM
Who gets Dermatomyositis?
It affects women about twice as often as men, with two peaks: childhood (juvenile dermatomyositis) and adults between 40 and 60. In adults over 40 there is an increased risk of an associated underlying cancer, which is why age-appropriate cancer screening is part of the initial assessment — a difficult conversation, but one that finds treatable disease early.
What are the symptoms of Dermatomyositis?
Not everyone has every symptom below, and having one does not confirm the diagnosis. These are the features that most often lead to assessment:
- Difficulty climbing stairs, rising from a chair or the floor, or lifting the arms overhead
- Weakness that is symmetrical and worsens over weeks to months
- A violet or dusky red rash on the eyelids, sometimes with swelling
- Raised scaly patches over the knuckles (Gottron's papules)
- A red rash across the upper chest, shoulders and upper back
- Ragged cuticles and prominent nail fold vessels
- Cracked, rough skin on the fingers ('mechanic's hands')
- Difficulty swallowing, choking, or a change in voice
- Dry cough or breathlessness where the lungs are involved
- Muscle pain, though weakness is more prominent than pain
- Joint pain, fever and weight loss
How is Dermatomyositis diagnosed?
Muscle enzymes — CK, aldolase, AST, ALT and LDH — are usually raised, though they can be normal in some subtypes, particularly anti-MDA5 disease.
Myositis-specific antibodies define the subtype and predict the risks: anti-Jo-1 and other antisynthetase antibodies indicate lung involvement, anti-MDA5 indicates rapidly progressive lung disease with minimal muscle involvement, anti-TIF1-gamma and anti-NXP2 indicate higher cancer risk.
MRI of the thigh muscles shows inflammation and guides where to biopsy. EMG shows the pattern of muscle involvement. Muscle biopsy confirms the diagnosis and separates dermatomyositis from other myopathies.
All adults have a CT of the chest, and lung function testing, because interstitial lung disease is common and often silent. Age-appropriate cancer screening is arranged.
How is Dermatomyositis treated?
High-dose corticosteroids begin treatment, tapered as a steroid-sparing agent takes effect.
Methotrexate, azathioprine or mycophenolate are the usual maintenance drugs. Intravenous immunoglobulin is effective, particularly for skin disease and swallowing difficulty. Rituximab is used in resistant disease, and rapidly progressive lung disease may need combined intensive immunosuppression.
Skin disease often persists after the muscles have recovered and is treated with hydroxychloroquine, topical treatment and rigorous sun protection.
Physiotherapy begins early — gentle at first, progressing as inflammation settles. Prolonged rest causes muscle loss that then has to be recovered separately from the disease.
Swallowing assessment is arranged where there is any choking or voice change, since aspiration is a serious risk.
Living with Dermatomyositis
Most patients improve substantially with treatment, though recovery of strength lags behind normalisation of blood tests by months, and physiotherapy through that period determines much of the final result. Sun protection is genuinely important because ultraviolet light drives the skin disease. Follow-up includes ongoing lung monitoring and, in adults, continued cancer surveillance for the first few years.
When should you see a rheumatologist?
Progressive difficulty climbing stairs or lifting the arms over weeks to months, particularly with a rash on the eyelids or knuckles, needs prompt assessment. Choking on food or breathlessness makes it urgent.
Common questions about Dermatomyositis
Why am I being screened for cancer?
In adults over 40, dermatomyositis carries an increased risk of an associated underlying cancer, highest in the first three years and with certain antibodies. Age-appropriate screening is done so that anything present is found early, when it is most treatable.
Will my strength come back?
Usually, substantially — but slowly. Blood tests normalise before strength does, and recovery takes months of graded physiotherapy. Rest beyond the earliest inflammatory phase causes muscle loss that then has to be regained separately.
Why do I need a lung scan when my problem is muscles?
Interstitial lung disease is common in dermatomyositis, particularly with certain antibodies, and is often silent early on. A baseline CT and lung function test detect it while it is still treatable.
My rash is worse than my weakness. Is that normal?
Yes. Some patients have prominent skin disease with little or no muscle involvement, called clinically amyopathic dermatomyositis. It still needs assessment, particularly for lung disease, which can be severe in this group.
This page is general information to support a consultation. It is not a diagnosis, and it does not replace an assessment by a doctor who has examined you.